These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30325612)
21. Open ureteroneocystostomy after failed endoscopic injection with three different bulking agents for the treatment of vesicoureteral reflux. Sencan A; Yıldırım H; Ozkan KU; Uçan B; Hoşgör M J Pediatr Surg; 2014 Nov; 49(11):1652-5. PubMed ID: 25475812 [TBL] [Abstract][Full Text] [Related]
22. Comparison of polyacrylate polyalcohol copolymer (PPC) and dextranomer/hyaluronic acid (Dx/HA) for treatment of vesicoureteral reflux. A systematic review and meta-analysis. Gholami B; Gholami S; Khodaei B; Sharifiaghdas F J Pediatr Urol; 2022 Oct; 18(5):664-673. PubMed ID: 36153243 [TBL] [Abstract][Full Text] [Related]
23. Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up. Sharifiaghdas F; Tajalli F; Otukesh H; Shamsabadi RH J Pediatr Urol; 2014 Dec; 10(6):1032-6. PubMed ID: 24953543 [TBL] [Abstract][Full Text] [Related]
25. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. Moore K; Bolduc S J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269 [TBL] [Abstract][Full Text] [Related]
26. Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and Safety. Ramsay S; Blais AS; Morin F; Moore K; Cloutier J; Bolduc S J Urol; 2017 Mar; 197(3 Pt 2):963-967. PubMed ID: 27575606 [TBL] [Abstract][Full Text] [Related]
27. Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: Comparison of Dexell and Vantris. Doğan AB; Özkan KU; Güler AG; Karakaya AE Actas Urol Esp (Engl Ed); 2021 Oct; 45(8):545-551. PubMed ID: 34526255 [TBL] [Abstract][Full Text] [Related]